Village Farms International Reports Q1 2026 Results with 118% Adjusted EBITDA Growth and Record International Export Sales

Key Takeaways

• Adjusted EBITDA jumps 118% to $10.2 million, 20.5% of sales
• International export sales surge 171% to $14.6 million, led by Germany
• Pure Sunfarms holds top‑five Canadian market share, #1 dried flower
• Delta 2 greenhouse expansion adds 40 tonnes capacity by 2027
• U.S. rescheduling to Schedule III could unlock new market opportunities

Pulse Analysis

Village Farms International’s Q1 2026 results illustrate how scale and operational efficiency are reshaping the cannabis sector. The company’s adjusted EBITDA more than doubled, outpacing revenue growth, thanks to higher gross margins and a surge in export sales. By leveraging EU‑GMP certification and a robust distribution network in Germany, Village Farms captured a record $14.6 million in export revenue, underscoring Europe’s rising appetite for regulated medical cannabis. The firm’s strategic focus on premium dried‑flower products, reinforced by Pure Sunfarms’ packaging upgrades, helped retain a top‑five position in Canada and a market‑leading rank in the dried‑flower category.

The Delta 2 greenhouse expansion is a cornerstone of Village Farms’ capacity‑building roadmap. Adding 40 metric tonnes of annualised production by 2027 will boost Canadian output by roughly one‑third, supporting both domestic demand and export pipelines. Simultaneously, the Phase II Netherlands facility is on track to quintuple local production to about 10 metric tonnes by year‑end, positioning the company as a key supplier in the European medical market. These capital projects illustrate a broader industry trend: vertically integrated growers are investing heavily in GMP‑compliant facilities to meet stringent regulatory standards and capture premium pricing.

Policy developments in the United States could further accelerate Village Farms’ growth trajectory. President Trump’s April 23 2026 executive order moving FDA‑approved and state‑licensed marijuana products to Schedule III initiates an expedited hearing process that may broaden legal access. For a company already positioned in high‑margin markets, the potential opening of a large U.S. consumer base presents a multi‑billion‑dollar upside. Village Farms’ disciplined capital allocation, coupled with an active M&A pipeline, suggests it is prepared to capitalize on both domestic regulatory shifts and expanding international demand.